Product Information
NITROFURANTOIN 25 MG/5 ML SUSP is a generic product labeled by Biocon Pharma Inc., priced at $1.6860 per ML under NDC 70377011831. Its NADAC has been published 90 times since Jan 15, 2025.
FDA first approved this application on Oct 28, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/5mL
Manufacturer
Biocon Pharma Inc.NDC
70377011831
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NITROFURANTOINApproval Type
Generic (ANDA)
FDA Application
ANDA218346FDA Approved
10/28/2024
TE Code
AB
On Market Since
11/15/2024
Pharmacological Classes
Price Statistics
The NADAC for NITROFURANTOIN 25 MG/5 ML SUSP has been published 90 times since Jan 15, 2025, and over the history we have for it it has declined 56.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6860 per ML |
|---|---|
| All-time high | $3.8712 (Jan 15, 2025) |
| All-time low | $1.6860 (Sep 23, 2026) |
| 52-week high | $2.8435 |
| 52-week low | $1.6860 |
| Median price | $2.5824 |
| Average price | $2.6070 |
| Largest weekly change | -14.9% (Jan 22, 2025) |
| Weeks tracked | 90 |
| Tracking since | Jan 15, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the NITROFURANTOIN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Biocon Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
NITROFURANTOIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitrofuran Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NITROFURANTOIN 25 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for NITROFURANTOIN 25 MG/5 ML SUSP, manufactured by Biocon Pharma Inc., is $1.6860 per ML (NDC 70377011831), effective Sep 30, 2026.
How has the price of NITROFURANTOIN 25 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for NITROFURANTOIN 25 MG/5 ML SUSP has declined 56.4%. It has been tracked across 90 weekly CMS publications since Jan 15, 2025.
What are the highest and lowest recorded NADAC prices for NITROFURANTOIN 25 MG/5 ML SUSP?
Since Jan 15, 2025, the NADAC for NITROFURANTOIN 25 MG/5 ML SUSP has ranged from a low of $1.6860 (Sep 23, 2026) to a high of $3.8712 (Jan 15, 2025), with a median of $2.5824 per ML.
Are there cheaper alternatives to NITROFURANTOIN 25 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of NITROFURANTOIN 25 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NITROFURANTOIN 25 MG/5 ML SUSP?
NITROFURANTOIN 25 MG/5 ML SUSP (NDC 70377011831) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.